This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Eli Lilly and Company.
Reference
Meyers J, et al. The Health Care Resource Utilization and Costs Among Patients With Type 2 Diabetes and Either Cardiovascular Disease or Cardiovascular Risk Factors An Analysis of a US Health Insurance Database. Clinical Therapeutics : 5 Oct 2021. Available from: URL: http://doi.org/10.1016/j.clinthera.2021.09.003
Rights and permissions
About this article
Cite this article
Economic burden for patients with T2DM and CVD substantial in the US. PharmacoEcon Outcomes News 890, 6 (2021). https://doi.org/10.1007/s40274-021-08129-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08129-0